EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
1.6.2.2 | NADH + methemoglobin |
- |
Rattus norvegicus |
NAD+ + hemoglobin |
- |
? |
1.6.2.2 | NADH + oxidized 2,6-dichlorophenolindophenol |
- |
Homo sapiens |
NAD+ + H+ + reduced 2,6-dichlorophenolindophenol |
- |
? |
1.6.2.2 | NADH + oxidized 2,6-dichlorophenolindophenol |
- |
Arabidopsis thaliana |
NAD+ + H+ + reduced 2,6-dichlorophenolindophenol |
- |
? |
1.6.2.2 | NADH + oxidized 2,6-dichlorophenolindophenol |
- |
Bos taurus |
NAD+ + H+ + reduced 2,6-dichlorophenolindophenol |
- |
? |
1.6.2.2 | NADH + oxidized 2,6-dichlorophenolindophenol |
- |
Propsilocerus akamusi |
NAD+ + H+ + reduced 2,6-dichlorophenolindophenol |
- |
? |
1.6.2.2 | NADH + oxidized cytochrome c |
- |
Sus scrofa |
NAD+ + H+ + reduced cytochrome c |
- |
? |
1.6.2.2 | NADH + oxidized nitroblue tetrazolium |
- |
Sus scrofa |
NAD+ + H+ + reduced nitroblue tetrazolium |
- |
? |
1.6.2.2 | NADPH + ferricytochrome b5 |
low affinity for NADPH |
Mus musculus |
NADP+ + H+ + ferrocytochrome b5 |
- |
? |
1.6.2.2 | nitrofurantoin + O2 + NADH + H+ |
- |
Homo sapiens |
? |
- |
? |
1.6.2.2 | sulfamethoxazole hydroxylamine + NADH |
in the presence of cytochrome b5 |
Homo sapiens |
? |
- |
? |